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Ozone-depleting solvents, such as specific
chloroﬂuorocarbons and 1,1,1-trichloroethane,
have been banned since 1996 in developed
countries. Because they were used in large
amounts in various industries, alternative com-
pounds were introduced to the workplace.
One such alternative compound is 1-bromo-
propane (1-BP; n-propylbromide, CAS
Registry no. 106-94-5), which is used in the
United States and Japan as a cleaning agent for
metals, precision instruments, electronics, opti-
cal instruments, and ceramics (Ichihara, in
press). It is also used in spray form as an adhe-
sive in the United States (Ichihara et al. 2002).
Environ Tech (2001) estimated the total
amount of 1-BP commercially available for sale
in the United States in the year 2000 was
1,967.9 metric tons (4,338,583 lb), which is
comparable to 9.0, 31.0, and 10.6% of the
amount of methylene chloride, perchloro-
ethylene, and trichloroethylene used in adhe-
sive/foam fabrication and metal cleaning in the
same year in the United States. In Japan, the
amount of 1-BP sold in 2003 was 1,125 metric
tons, which is about double the 645 metric tons
sold in 1998 (Association of Bromopropane
Producers of Japan, unpublished data). In
addition, in the workplace where cases of
neurotoxicity had been reported, 1-BP was
introduced as an alternative for methylene
chloride (Ichihara et al. 2002). The beneﬁts of
using 1-BP instead of the chlorinated carbons
are not clear. However, under pressure to regu-
late the use of chlorocarbons, 1-BP has been
used as a surrogate, which is encouraged by the
lack of measures to deﬁne the exposure limits.
In this regard, previous animal studies revealed
neurotoxicity and reproductive toxicity of 1-
BP (Ichihara et al. 2000a, 2000b; Wang et al.
2002, 2003; Yamada et al. 2003; Yu et al.
1998, 2001). Exposure to 1-BP resulted in a
dose-dependent limb muscle weakness and
reduction of nerve conduction in rats (Ichihara
et al. 2000a). It also resulted in myelin degen-
eration of peripheral nerves and swelling of
preterminal axons in the medulla oblongata
(Ichihara et al. 2000a). It was also revealed that
1-BP exhibits reproductive toxicity in both
male and female rats (Ichihara et al. 2000b;
Yamada et al. 2003). Thus, animal studies pre-
ceded human studies and warned about the
potential neurotoxicity and reproductive toxic-
ity of 1-BP in humans. The most recently
reported cases also conﬁrmed the neurotoxicity
of 1-BP in humans (Ichihara et al. 2002; Sclar
1999). However, these case reports have limi-
tations in terms of quantitative analysis. In
1999 we investigated a 1-BP factory, but this
investigation was also limited because it was
originally oriented to study the effects of
2-bromopropane (2-BP), which targets mainly
reproductive and hematopoietic systems
(Ichihara et al. 2004).
The aim of the present study was to assess
the neurologic function and other health-
related changes in workers exposed to 1-BP
and compare the results with those of control
workers in a beer factory.
Materials and Methods
Factories and workers. The subjects were
female workers of a 1-BP production factory
located in Yixing, Jiangsu Province, China.
The survey was conducted 16–18 January
2001. The same factory mainly produced 2-BP
in 1996 (Ichihara et al. 1999), but shifted the
main production to 1-BP between 1996 and
1999 (Ichihara et al. 2004), and the product
was only 1-BP at the time of the present survey.
1-BP was synthesized by incubating n-propra-
nolol and hydrogen bromide under concen-
trated sulfuric acid. The product was puriﬁed
by distillation and temporarily stored in
ceramic containers. The crude product was
then transferred to 20-L plastic vessels through
hose pipe from the cock of the container and
subsequently neutralized with hydrogen car-
bonate. The product was ﬁnally transferred to
1,000-L drums for storage and transport. The
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We reported recently that 1-bromopropane (1-BP; n-propylbromide, CAS Registry no. 106-94-5),
an alternative to ozone-depleting solvents, is neurotoxic and exhibits reproductive toxicity in rats.
The four most recent case reports suggested possible neurotoxicity of 1-BP in workers. The aim of
the present study was to establish the neurologic effects of 1-BP in workers and examine the rela-
tionship with exposure levels. We surveyed 27 female workers in a 1-BP production factory and
compared 23 of them with 23 age-matched workers in a beer factory as controls. The workers were
interviewed and examined by neurologic, electrophysiologic, hematologic, biochemical, neuro-
behavioral, and postural sway tests. 1-BP exposure levels were estimated with passive samplers.
Tests with a tuning fork showed diminished vibration sensation of the foot in 15 workers exposed
to 1-BP but in none of the controls. 1-BP factory workers showed signiﬁcantly longer distal latency
in the tibial nerve than did the controls but no significant changes in motor nerve conduction
velocity. Workers also displayed lower values in sensory nerve conduction velocity in the sural
nerve, backward recalled digits, Benton visual memory test scores, pursuit aiming test scores, and
five items of the Profile of Mood States (POMS) test (tension, depression, anxiety, fatigue, and
confusion) compared with controls matched for age and education. Workers hired after May 1999,
who were exposed to 1-BP only (workers hired before 1999 could have also been exposed to 2-BP),
showed similar changes in vibration sense, distal latency, Benton test scores, and depression and
fatigue in the POMS test. Time-weighted average exposure levels in the workers were
0.34–49.19 ppm. Exposure to 1-BP could adversely affect peripheral nerves or/and the central ner-
vous system. Key words: 1-bromopropane, distal latency, nerve conduction velocity, neuro-
behavioral testing, neurotoxicity, ozone-depleting solvents, postural sway testing, reproductive
toxicity, vibration sense. Environ Health Perspect 112:1319–1325 (2004). doi:10.1289/ehp.6995
available via http://dx.doi.org/ [Online 30 June 2004]
Environmental Medicine Articleworkers were at risk of exposure to 1-BP when
a) placing the chemicals into the reaction pots;
b) sitting close to the reaction pots to observe
and record the temperature; c) taking out the
crude product; d ) adding the hydrogen car-
bonate and stirring; and e) pouring the product
into the drums. In the ﬁnal step, the workers
added the product with hand scoops to adjust
the product volume in the drum.
The surveyed factory has two similar-sized
manufacturing plants, each measuring 9.7 ×
24.4 × 7m   (width × depth × height). In each
plant, a ventilating fan was ineffectively
installed 6 m from the ﬂoor; no local ventila-
tion fan was installed in the vicinity of the
areas where workers might be exposed to 1-BP.
The 27 surveyed workers who were engaged in
the production of 1-BP in the factory were all
female. As controls, we selected age-matched
(± 2 years) females at random from 202 female
workers in a beer factory in the same city. The
control workers lived in the same area.
In the analysis of paired t-tests between
1-BP workers and controls, four 1-BP workers
were excluded because no corresponding match
of control workers from the beer factory could
be recruited. However, the analysis by exposure
level or period of exposure included those 1-BP
female workers for whom no corresponding
age-matched controls could be recruited. All
workers who were hired after 1991 and for
whom corresponding age-matched controls
could be recruited were identified as 1991
workers. Among them, the workers who were
hired after 1999 and were exposed only to 1-BP
were deﬁned as 1999 workers.
Medical examination. Signed informed
consent was obtained from each worker for all
examinations and interviews, according to the
Declaration of Helsinki (World Medical
Association 2002). All female workers in the
1-BP factory and the 23 age-matched beer-
factory workers were clinically examined by a
trained Chinese neurologist who was con-
ducting medical research at the Department
of Neurology, Nagoya University, Japan, and
had a good command of both Chinese and
Japanese languages.
The vibration sensation was evaluated
using a vibrating tuning fork (128 Hz); the
fork was placed on the dorsum of the
metatarsophalangeal joint of the big toe or the
dorsum of the metacarpophalangeal joint of
the thumb, and the worker was asked to
report when the vibration ceased. Immediately
after reporting, the tuning fork was moved to
the same site (big toe or thumb) of the exam-
iner and the duration of the lasting vibration
after the worker’s report was recorded. It was
difficult to assess the actual time when the
delay time was < 2 sec, because it took some
time (but < 2 sec) to move the tuning fork
from the worker’s body to the examiner’s
body. In addition, one worker reported total
loss of vibration sense in the right toe.
Therefore, the value could not be treated as a
continuous value in the statistical analysis. The
examiner was a trained female (38-year-old)
neurologist who worked with every worker
throughout the investigation.
Electrophysiologic studies. We conducted
electrophysiologic studies in an air-conditioned
room maintained at 24°C. The workers were
acclimated to the room temperature for
30 min before the electrophysiologic studies.
We examined distal latency (DL), motor nerve
conduction velocity (MCV), F-wave conduc-
tion velocity (FWCV), and sensory nerve con-
duction velocity (SNCV). Electric stimulation
and recordings were performed with a
Neuropack evoked potential/electromyogram
measurement system (model MEB5508;
Nihon Kohden, Co., Tokyo, Japan). For
measurement of DL and MCV, the stimula-
tion site was just behind the medial malleolus
(distal) and the center of poples (proximal),
and the recording site was ﬁxed 11 cm distal
to the distal stimulation site on the abductor
hallucis muscle.
Blood tests. The following blood tests were
performed in each worker: red blood cell
(RBC) count, hemoglobin, hematocrit, white
blood cell (WBC) count, and platelet count,
using a hematocell counter (Coulter JT,
Coulter Electronics, Hialeah, FL, USA), as
well as fructosamine (colorimetric method),
blood urea nitrogen [urease ultraviolet (UV)
method], creatinine (enzyme method), total
protein (Biuret method), total cholesterol
(enzyme method), creatine kinase (UV
N-acetylcysteine method), aspartate amino-
transferase (UV method), alanine aminotrans-
ferase (UV method), γ-glutamyl transferase
(L-γ-glutamyl-3-carboxy-4-nitroanilide sub-
strate method), lactate dehydrogenase
(Wroblewski-LaDue method), alkaline phos-
phatase (p-nitrophenol substrate method),
serum creatinine (alkaline picric acid method),
vitamin B1 (HPLC method), iron [2-nitroso-
5-(N-propyl-N-sulfopropylamino)phenol
method], ferritin, thyroid-stimulating hor-
mone [radioimmunoassay (RIA)], luteinizing
hormone (LH; RIA), follicle-stimulating hor-
mone (FSH; RIA), and estradiol (RIA).
Neurobehavioral tests and postural sway
test. Neurobehavioral testing [simple reaction
time, digit span, Santa Ana, digit symbol,
Benton, pursuit aiming test, Proﬁle of Mood
States (POMS)] was conducted based on the
Chinese edition of the World Health
Organization Neurobehavioral Core Test
Battery (Chen 1988; Liang 1987) by trained
Chinese researchers. Because neurobehavioral
tests can be inﬂuenced by education level, we
also conducted analyses with controls matched
for age and education level. Postural balance
was measured with a Gravicorder GS-30
stabilometer (Anima Co., Tokyo, Japan). The
same instrument was used in all subjects
throughout the investigation. Postural sway
testing was performed as described previously
(Yamamoto et al. 2001; Yokoyama et al.
1997). Brieﬂy, the subject was asked to stand
with big toes touching each other on the plat-
form of the Gravicorder. The center of gravity
was recorded every 50 msec with both eyes
open for 1 min and closed for 1 min. The cal-
culated values based on the center of gravity
were a) the total length of excursion; b) enve-
lope area; c) length of excursion per envelope
area; d) rectangular area, representing the
product of the range of the x-component (lat-
eral) and that of the y-component (anteropos-
terior); e) root mean square area; f) the mean
of x-axis or y-axis component of each recorded
point; g) the center of range of the x-axis or
y-axis component of points; h) power spec-
trum of the x-axis or y-axis at 0.02–0.2 Hz,
0.2–2.0 Hz, and 2.0–10.0 Hz, obtained by
frequency analysis, with both eyes open and
closed; and i) the Romberg quotient, repre-
senting the ratio of values measured with eyes
closed to the value with eyes open for items
a through h. 
Assessment of exposure to 1-BP. Individual
exposure levels during work shifts were evalu-
ated with passive samplers (Sibata Scientific
Technology Ltd., Tokyo, Japan) using the
method described previously by Ichihara et al.
(2004). A passive sampler was attached to
each worker during one 8-hr shift and was
collected immediately after the shift and kept
in separate sealed bags at 4°C until analysis.
The absorbed solvent in the sampler was ana-
lyzed 2 weeks after the investigation. In our
previous study (Ichihara et al. 2004), we con-
ﬁrmed the stability of absorbed 1-BP in char-
coal at 4°C for 2 weeks. For analysis, activated
charcoal particles were taken from the samplers
and then immersed in 2 mL carbon disulﬁde
(Wako Pure Chemicals, Osaka, Japan) in a
glass tube with a screw cap. The tube was
shaken vigorously for 5 min and left to stand
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Table 1. Characteristics of workers.
1-BP exposed Control
Characteristic (n = 23) (n = 23)
Age (years) 36.2 ± 5.7a 36.2 ± 5.2
Height (cm) 160.3 ± 6.6a 158.8 ± 5.9
Education
Elementary school 4 4
Junior high school 19 12
High school 0 6
University 0 1
Job duration (months) 27 ± 31 168 ± 67
Past job exposure to chemicals 0 4b
Previous medical condition 2c 8d
Data for age, height, and job duration are mean ± SD.
Other values are numbers of workers. 
aNot signiﬁcantly different from the controls (paired t-test).
bIncludes formalin (2), ammonia (1), alkaline (1). cIncludes
cholecystitis (1), contraceptive use (1). dIncludes anemia
(2), gastritis (2), hysteromyoma (2), oophoritic cyst (1),
cholecystitis (1), taking antihypertensive medications (1).for 1 hr; the supernatant was then injected
into a gas chromatograph equipped with an
electron ionization detector (GCD system
G1800A, Hewlett Packard, Palo Alto, CA,
USA). The concentration of 1-BP was quanti-
ﬁed by the selected ion mode. The detection
limit was 0.007 ppm by this method. The
time-weighted average (TWA) was calculated
based on the formula 
In our calculations, we used the value of 0.134
as the sampling rate of 1-BP. The value was
determined by the diffusing cell method.
Statistical analysis. We used the paired
t-test to compare continuous parameters of the
exposure group and controls matched for age
or age and education level. In this analysis, all
indices of electrophysiologic studies, neuro-
behavioral tests, POMS test, stabilometer test-
ing, and blood tests were compared with the
age-matched controls, and the indices of
neurobehavioral tests and POMS were also
compared with controls matched for age and
education level. We used the Wilcoxon test
and Fisher’s exact test to compare the delay
time and abnormality of menstrual cycles,
respectively, of the exposure group and the
age-matched controls. In the analysis by expo-
sure levels, the 27 exposed workers were classi-
ﬁed into two groups: ≤ 2.64 ppm (n = 17) and
≥ 8.84 ppm (n = 7); data missing (n = 3). For
analysis by length of exposure, the 27 exposed
workers were again classiﬁed into two groups:
≤ 9.31 months (n = 10) and ≥ 16.33 months
(n = 16); data missing (n = 1). We selected
these cutoff values because they divided the
two peak distributions when the histograms
with column width of 2.5 ppm and 5 months,
respectively, were drawn, whereas no values
were found between 2.64 and 8.84 ppm and
9.31 and 16.33 months. In comparisons
between groups stratified with fructosamine
[≤ 246 µmol/L (n = 14) and 248–284 µmol/L
(n = 13)] or vitamin levels [20–30 ng/mL
(n = 13) and ≥ 31 ng/mL (n = 13); data miss-
ing (n =1 )], the groups were divided accord-
ing to the median because there was no split in
the distribution that formed two peak distrib-
utions. The t-test was applied when compar-
ing continuous variables (electrophysiologic
tests, neurobehavioral tests, POMS test, sta-
bilometer tests, and blood tests) by exposure
levels or length of exposure as well as the levels
of fructosamine or vitamin B1. For the analysis
of delay time and frequency of menstrual
cycles, we used Wilcoxon test and Fisher’s
exact test, respectively, for comparison accord-
ing to exposure levels, length of exposure, and
the level of fructosamine or vitamin B1. We
defined significance as the probability of
p < 0.05. 
Results
There were no differences in age and height
between 1-BP workers and the age-matched
controls (Table 1). The control group had a
higher education level than the exposure
group. Job duration of the exposure group
was shorter than for the controls, probably
because the area where the workers lived had
been developed quite recently, so they had
engaged in agriculture before employment in
the factory. Four workers in the beer factory
(controls) had been exposed to various chemi-
cals (formalin, n = 2; ammonia, n = 1; alkaline
reagent, n = 1) in occupational settings before
their present jobs. None of the workers inves-
tigated was a smoker, and only one exposed
worker and one control worker were alcohol
drinkers. None of the workers investigated
had a history of diabetes mellitus, which could
cause polyneuropathy. Individual exposure
levels ranged from 0.34 to 49.2 ppm (median,
1.61 ppm; geometric mean, 2.92; Figure 1).
Bromopropane workers, all of whom were
hired after 1991 (1991 workers), had signiﬁ-
cantly longer DL and lower SNCV than did
the age-matched controls (Table 2). Because
the main product in the factory had shifted
from 2-BP to 1-BP between 1996 and May
1999 (Ichihara et al. 2004), we also analyzed
data for 1999 workers to examine the effects
of exposure to 1-BP only. Examination of
these workers showed the only significant
change to be an increase in the DL compared
with age-matched controls. However, the
extent of the change in any electrophysiologic
parameter in the 1999 workers tended, in gen-
eral, to be similar to that of the 1991 workers.
Reduced vibration sensation as tested on the
right toe, left toe, right ﬁnger, and left ﬁnger
was detected in 15, 13, 4, and 4 female work-
ers, respectively (Tables 3 and 4). One worker
showed complete loss of vibration sense on the
right toe by tuning fork stimulation. The expo-
sure level for this worker was 1.10 ppm, and
she had a relatively high DL (8.8 msec) and
low MCV (43.1 m/sec), FWCV (53.7 m/sec),
and SNCV (38.8 m/sec). In contrast, none of
the age-matched beer workers showed any
abnormalities in vibration sensation in the toe
and ﬁnger. The Wilcoxon test showed signiﬁ-
cant differences in the delay time bilaterally
both in the feet and in the fingers between
1991 workers and controls. Analysis of
1999 workers also showed signiﬁcant prolon-
gation of the delay time on the toes bilaterally
but not in the fingers. The percentage of
1999 workers who showed reduced vibration
sensation (delay time ≥ 2 sec) on both sides of
the foot and in the ﬁngers was similar to that
of 1991 workers.
Neurobehavioral tests showed lower values
for the forward and backward digit span,
Benton visual memory test, pursuit aiming
test, POMS test (scores for tension, depres-
sion, anxiety, fatigue, and confusion) in the
1-BP workers than in the controls (Tables 5
and 6). Because the education level of 1-BP
workers was different from that of the age-
matched controls and because the education
level could affect the results of neurobehav-
ioral tests, these tests were analyzed after
matching both education level and age
(Tables 5 and 6). 1-BP workers had lower lev-
els of backward digit span; correct scores in
the Benton visual memory test; completed
response in the pursuit aiming test; and ten-
sion, depression, anxiety, fatigue, and confu-
sion in the POMS test than did controls
matched for age and education level. Further
analysis was conducted for these neurobehav-
ioral tests on 1999 workers (Tables 5 and 6).
Signiﬁcant differences with the controls were
found only in the Benton visual memory test
and in POMS depression and fatigue. 
The postural sway tests showed signifi-
cantly lower power spectrum of the x-axis at
2.0–1.0 Hz with eyes open and y-axis at
0.02–0.2 Hz with eyes closed and signiﬁcantly
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Figure 1. Exposure levels of each worker in a 1-BP
factory (TWA for 8-hr shift). Values were obtained
with passive samplers from workers who had age-
matched controls (n=23). Maximum = 49.19; minimum
=0.34; median = 1.61; geometric mean = 2.92 ppm.
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Table 2. Electrophysiologic indices of workers exposed to 1-BP and of the controls.
Age-matched Age-matched
1991 workers  controls for 1991 1999 workers  controls for 1999
No. of pairs 23 12
DL of nervus tibialis (msec) 8.05 ± 2.17* 5.96 ± 1.38 8.36 ± 2.38* 6.06 ± 1.43
MCV of nervus tibialis (m/sec) 49.8 ± 10.3 49.9 ± 8.2 51.3 ± 12.0 51.7 ± 10.7
FWCV of nervus tibialis (m/sec) 52.8 ± 3.5 55.1 ± 3.2 51.8 ± 2.8 55.0 ± 2.9
SNCV of nervus suralis (m/sec) 39.2 ± 3.5* 46.2 ± 6.6 39.2 ± 2.6 47.5 ± 8.5
Data are mean ± SD. 
*p < 0.05 compared with age-matched controls (paired t-test).higher power spectrum of the y-axis at
0.2–2.0 Hz with eyes closed (Table 7) in the
1999 workers than in the age-matched con-
trols, but other parameters were not signifi-
cantly different between the two groups
(Table 7; Romberg quotients for all items,
which also did not show any statistical differ-
ence, are not shown). The comparison of the
1999 workers and age-matched controls did
not show any signiﬁcant differences in postural
sway tests (Table 7; Romberg quotients not
shown).
Laboratory tests did not show any signiﬁ-
cant differences between the 1991 workers
and age-matched controls (data not shown)
except for significantly lower levels of
vitamin B1 (31.0 ± 5.6 vs. 34.3 ± 5.4 ng/mL)
and low WBC count (5.7 ± 1.7 × 103/µL vs.
6.7 ± 1.8 × 103/µL) in the 1991 workers than
in age-matched controls. For 1999 workers,
only the WBC count was signiﬁcantly lower
than in the age-matched controls. In only one
worker (42 years of age) in the control group,
the fructosamine level (286 µmol/L) was
above the upper limit of reference value
(205–285 µmol/L). This worker had rather
high DL (8.24 msec) and low levels of MCV
(42.5 m/sec), FWCV (49.8 m/sec), and SNCV
(39.5 m/sec) but did not show abnormal vibra-
tion sensation. This worker was not included
in the education-matched testing because she
had no education-matched individual in the
exposure group. Comparison between the two
groups stratiﬁed by fructosamine levels within
all exposed workers (n = 27) showed signifi-
cant differences only in higher levels of total
protein (8.22 ± 0.53 g/dL), total cholesterol
(197.7 ± 32.1 mg/dL), choline esterase (ChE;
366.1 ± 86.7 IU/L), LH (14.3 ± 14.3 IU/L),
WBC (6.62 ± 5.15 × 103/µL), RBC (4.19 ±
0.38 × 106/µL), POMS confusion (5.31 ±
4.35), and lower estradiol level (35.4 ±
25.1 pg/mL) in the high-fructosamine group
compared with the low-fructosamine group
(total protein, 7.64 ± 0.24 g/dL; LH, 4.2 ±
3.4 IU/L; total cholesterol, 166.5 ± 28.7
mg/dL; ChE, 288.4 ± 37.8 IU/L; WBC, 5.16
± 0.97 × 103/µL; RBC, 3.84 ± 0.38 × 106/µL;
POMS confusion, 2.36 ± 1.91; estradiol, 63.2
± 38.3 pg/mL).
Fisher’s exact test did not show any dif-
ference between the 1991 and 1999 worker
groups and their corresponding age-matched
control groups with regard to the frequency
of menstrual abnormalities after starting
working in the 1-BP factory. Two workers
in the exposure group had a short menstrual
cycle. Similarly, one worker in the control
group had a short menstrual cycle, and
another reported a prolonged period of 
menstrual bleeding.
On the other hand, a comparison based
on the exposure levels (≤ 2.64 or ≥ 8.84 ppm)
showed that workers with high exposure levels
showed significantly high values of MCV
(56.4 ± 12.9 m/sec), FWCV (54.7 ±
2.8 m/sec), hematocrit (0.393 ± 0.032), and
POMS tension (5.14 ± 1.77) and lower values
of FSH (9.0 ± 6.3 mIU/mL) and POMS
vigor (18.6 ± 2.5), compared with the low-
exposure group (MCV, 47.3 ± 8.3 m/sec;
FWCV, 52.0 ± 1.9 m/sec; hematocrit, 0.356
± 0.034; POMS tension, 2.73 ± 1.49; FSH,
27.7 ± 35.3 mIU/mL; POMS vigor, 24.3 ±
4.0) but did not show any signiﬁcant associa-
tion with other examined indices. In the com-
parison by the length of exposure (≤ 9.31 or
≥ 16.33 months), the longer-exposure group
had high levels of LH (13.5 ± 13.7 mIU/mL)
and FSH (34.9 ± 34.9 mIU/mL) and lower
levels of total protein (7.77 ± 0.30 g/dL)
and vitamin B1 (29.2 ± 5.1 ng/mL) than did
the shorter-exposure group (LH, 3.3 ±
1.8 mIU/mL; FSH, 5.5 ± 2.1 mIU/mL; total
protein, 8.18 ± 0.66 g/dL; vitamin B1, 33.2 ±
5.0 ng/mL) but did not show any signiﬁcant
association with other examined indices.
Because the mean concentration of vita-
min B1 was signiﬁcantly lower in the exposure
group than in the controls, the values were
compared between the two groups stratified
by vitamin B1 level within all exposed workers
(n = 27). The comparison did not reveal any
difference in the frequency of low vibration
sensation or results of electrophysiologic tests,
apart from lower levels of alkaline phosphatase
(ALP; 129.3 ± 30.7 IU/L) and ChE (293.8
± 52.8 IU/L) in the low vitamin group than
high vitamin group (ALP, 169.5 ± 43.1 IU/L;
ChE, 361.8 ± 84.1 IU/L).
Discussion
In the tested factory, isopropanol, hydrogen
bromide, and sulfuric acid were also used as
materials in the process of producing 1-BP.
These chemicals are not considered to have
neurotoxic effects, so it is unlikely that the low
vibration sensation or change in DL is due to
these chemicals. In the last survey of the same
factory (Ichihara et al. 2004), we found that
the main product of this factory was shifted
from 2-BP to 1-BP. 1991 Workers include the
workers who were hired before May 1999 and
might have been exposed to not only 1-BP but
also 2-BP before 1999 (Ichihara et al. 1999).
In contrast, 1999 workers were exposed to
1-BP only. Therefore, the observed changes in
the DL, vibration sense in both feet bilater-
ally, Benton visual memory test score, and
depression and fatigue in the POMS test that
were noted in 1999 workers are considered to
be due to exposure to 1-BP. However, the
effects of 2-BP cannot be excluded in
1991 workers. The SNCV showed signiﬁcant
changes in the analysis of 1991 workers but
not in 1999 workers with age-matched con-
trols. This is most likely due to the lack of
power as a result of the reduction in the num-
ber of subjects, given the fact that the extent
of change in sensory nerve conduction, as well
as other electrophysiologic parameters, and
the percentage of workers who showed
reduced vibration sense among 1999 workers
was similar to that of 1991 workers. This
explanation might also be valid for other
parameters that showed signiﬁcant change in
1991 workers but not in 1999 workers.
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Table 3. Number of workers with reduced vibration sensation in the foot.
1991 workers and age-matched  1999 workers and age-matched 
controls (n = 23 pairs) controls (n = 12 pairs)
Delay timea Right foot* Left foot* Right foot* Left foot*
(sec) 1-BP workers Controls 1-BP workers Controls 1-BP workers Controls 1-BP workers Controls
< 2 8 23 10 23 5 12 5 12
20 0 1 0 0 0 1 0
33 0 1 0 1 0 1 0
42 0 4 0 1 0 1 0
52 0 1 0 1 0 0 0
64 0 4 0 3 0 2 0
83 0 1 0 1 0 1 0
10 0 0 10 0 0 10
∞b 1000 0 0 00
aDelay time for vibration sensation by tuning fork stimulation (see “Materials and Methods” for details); time 0 is the time
when the worker reported becoming unaware of the vibration. bOne worker felt no vibration sense in the right foot.
*p < 0.05, Wilcoxon test. 
Table 4. Number of workers with reduced vibration sensation in the ﬁnger.
1991 workers and age-matched 1999 workers and age-matched
controls (n = 23 pairs) controls (n = 12 pairs)
Delay timea Right ﬁnger* Left ﬁnger* Right ﬁnger Left ﬁnger
(sec) 1-BP workers Controls 1-BP workers Controls 1-BP workers Controls 1-BP workers Controls
< 2 19 23 19 231 0 1 21 0 1 2
23 0 2 0 2 0 2 0
31 0 2 0 1 0 0 0
aDelay time for vibration sensation by tuning fork stimulation (see “Materials and Methods” for details); time 0 is the time
when the worker reported becoming unaware of the vibration. *p < 0.05, Wilcoxon test.Our animal studies (Ichihara et al. 2000a;
Yu et al. 1998) preceded human case reports in
revealing the neurotoxicity of 1-BP, which is
far more potent than that of 2-BP (Yu et al.
1999, 2001). However, the results of animal
studies had certain limitations in predicting
symptoms or signs in human cases; for exam-
ple, animal studies cannot detect any subjective
symptoms that might reﬂect abnormalities of
sensation or the central nervous system. It is
sometimes difﬁcult especially for morphologic
studies to substantiate the adverse effects on
the central nervous system because the struc-
ture of the central nervous system is far more
robust than that of peripheral nerves or other
organs. It is also difﬁcult to evaluate imbalance
during walking in rodents because four-footed
animals are completely different from bipedal
humans regarding the clinical signs of imbal-
ance. Thus, information from human cases
should help us understand the toxicologic tar-
gets of 1-BP. The first case was reported by
Sclar (1999), and three other cases were
recently reported by our group (Ichihara et al.
2002). All four cases showed diminished vibra-
tion sensation in the toe. Moreover, the pre-
sent study showed that more than half of the
workers exposed to 1-BP suffered from
reduced vibration sensation. Considered
together, these results suggest that vibration
sensation in the toe might be susceptible to
exposure with 1-BP. The previously reported
cases also complained of urinary incontinence;
numbness in the perineum, low back, and
front of the thighs or buttocks; or headache
(Ichihara et al. 2002); however, our factory
workers did not report any such symptoms.
This difference might depend on the levels or
period of exposure to 1-BP because it is possi-
ble that our workers adapted to low levels but
longer periods of exposure, leading to unaware-
ness of symptoms.
In comparisons with age-matched controls,
both the 1991 workers and 1999 workers
showed prolonged DL but no change in
MCV. This prolongation of DL without
decrease in MCV parallels the results of animal
studies, which showed earlier changes in DL
than MCV in the tail nerve (Ichihara et al.
2000a). Such a pattern of changes might indi-
cate predominant deterioration of the distal
portion of the peripheral nerve or delay in
chemical transmission between nerve terminals
and muscle.
Comparison of data of 1991 workers with
age-matched controls showed that the exposure
group had lower levels of forward and back-
ward digit span, Benton scores, pursuit aiming
test scores, and POMS tension, depression,
anxiety, fatigue, and confusion than did the
controls. Because education level could inﬂu-
ence the results of neurobehavioral tests, the
results of the tests were reanalyzed after match-
ing age and education levels. This reanalysis
also revealed changes in the above items
excluding forward digit span. When the analy-
sis was limited to the 1999 workers, signiﬁcant
differences were found only in Benton visual
memory test scores, POMS depression, and
POMS fatigue, which could reﬂect the lack of
power due to the small sample number. Digit
span, pursuit aiming test, and the POMS test
are considered the most sensitive indicators of
exposure to organic solvents or neurotoxic
agents such as lead (Zhou et al. 2002). Poorer
performance in the POMS test was also
observed in a Venezuelan study of workers
exposed to organic solvents (Escalona et al.
1995). The present results of neurobehavioral
tests could also suggest that 1-BP adversely
affects the central nervous system in humans.
Postural sway tests showed higher power of the
y-axis (anterior–posterior sway) at 0.2–2.0 Hz
and lower at 0.02–0.2 Hz with eyes closed,
although such signiﬁcant differences were not
observed in 1999 workers. These results might
be important because the cases found in the
United States also showed unstable balance in
walking. Clinically, patients with cerebellar dis-
ease and anterior lobe atrophy show antero-
posterior sway, often with a spontaneous
high-frequency body tremor of around 3 Hz
(Diener et al. 1984). This anteroposterior sway
might resemble the present result of the
increase in the power of the y-axis at 0.2–2 Hz.
However, the results of the postural sway tests
noted in our study await further conﬁrmation
because the presence of cerebellar disorder in
the formerly reported cases or present workers
is not conclusive, and it is possible to attribute
the unstable balance to a disorder of the
peripheral nerves or spinal cord.
Diabetes mellitus could be a common con-
founding factor related to neurologic disorders
by solvent intoxication. HbA1C and fruc-
tosamine are used as long-term (Bunn et al.
1976) and intermediate-term (1–3 weeks)
(Baker et al. 1983) indicators of glucose levels
in clinical settings. In the present study, we
measured serum fructosamine levels. For the
measurement of HbA1C, the blood samples
had to be kept at 4°C but not frozen. However,
the long transportation from the factory site to
the laboratory could have potentially caused
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Table 5. Results of neurobehavioral tests in the 1-BP group and controls matched for age or for age and education (mean ± SD).
1991 workers 1991 workers 1999 workers
Test (age-matched controls) (age/education-matched controls) (age/education-matched controls)
No. (pairs) 22 12 6
Simple reaction time (sec) 0.38 ± 0.12 (0.36 ± 0.12) 0.38 ± 0.12 (0.36 ± 0.12) 0.40 ± 0.14 (0.39 ± 0.12)
Digit span (digits recalled) forward 10.6 ± 2.3* (11.7 ± 1.4) 10.8 ± 2.5 (11.8 ± 1.3) 10.2 ± 3.1 (12.0 ± 1.1)
Digit span (digits recalled) backward 4.5 ± 2.2* (5.8 ± 1.8) 5.0 ± 2.6* (5.6 ± 1.4) 4.2 ± 2.3 (6.2 ± 1.6)
Santa Ana preferred hand 35.2 ± 3.6 (36.6 ± 4.8) 35.3 ± 4.0 (36.1 ± 4.3) 36.0 ± 2.4 (35.8 ± 5.2)
Santa Ana nonpreferred hand 33.5 ± 4.6 (32.8 ± 5.1) 33.8 ± 5.2 (33.7 ± 5.6) 32.8 ± 4.4 (35.5 ± 5.9)
Digit symbol (no. completed) 47.0 ± 17.5 (54.0 ± 10.2) 48.6 ± 19.8 (55.5 ± 5.6) 45.3 ± 21.9 (56.7 ± 6.7)
Benton (no. correct) 7.2 ± 1.7* (8.3 ± 1.4) 7.8 ± 1.5* (8.2 ± 1.3) 7.3 ± 1.8* (8.3 ± 1.0)
Pursuit aiming test (no. completed) 103.1 ± 16.9* (119.9 ± 19.1) 101.6 ± 17.9* (119.3 ± 20.4) 98.0 ± 11.4 (125.7 ± 17.0)
*p < 0.05, paired t-test.
Table 6. Results of POMS tests in the 1-BP group and controls matched for age or for age and education (mean ± SD).
1991 workers 1991 workers 1999 workers
Test (age-matched controls) (age/education-matched controls) (age/education-matched controls)
No. (pairs) 20 12 6
Proﬁle of mood state
Tension 4.4 ± 3.9* (7.7 ± 7.1) 4.1 ± 5.2* (10.2 ± 8.5) 6.8 ± 7.0 (9.6 ± 7.2)
Depression 4.8 ± 7.5* (10.5 ± 13.0) 5.6 ± 10.1* (13.3 ± 17.1) 10.0 ± 14.4* (12.8 ± 16.0)
Anxiety 4.1 ± 5.0* (10.2 ± 10.2) 4.7 ± 6.3* (12.6 ± 13.2) 7.0 ± 9.0 (13.4 ± 12.7)
Vigor 22.2 ± 4.3 (20.7 ± 6.7) 23.7 ± 3.9 (20.9 ± 6.9) 23.4 ± 4.5 (21.4 ± 9.2)
Fatigue 3.1 ± 2.6* (6.4 ± 4.0) 3.0 ± 3.4* (6.7 ± 5.2) 4.4 ± 4.8* (7.2 ± 3.8)
Confusion 3.7 ± 3.7* (7.1 ± 4.3)  3.3 ± 4.4* (7.7 ± 5.6) 5.0 ± 6.2 (5.6 ± 5.0)
*p < 0.05, paired t-test.hemolysis of the collected blood and thus may
have resulted in marked variability and errors in
estimations. For this reason, HbA1C was not
measured in the present study. The comparison
between the exposed group and the controls did
not show any difference in the level of fruc-
tosamine, and the comparison between the
high-fructosamine group and low-fructosamine
group within the exposed group also did not
show any difference in indices related to the
nervous system.
The levels of vitamin B1 were lower in the
entire exposure group than in the controls and
in the longer-exposure group compared with
the shorter-exposure group. Lack of vitamin
B1 is known to cause polyneuropathy, but the
relatively low level of vitamin B1 in the 1-BP
factory workers could not fully explain the
neurologic abnormalities. First, the level of vit-
amin B1 in the exposed workers ranged from
20 to 43 ng/mL, which was within the normal
range (20–50 ng/mL). Second, the low-level
vitamin B1 group showed no neurologic
deﬁcit such as vibration sensation or electro-
physiologic indices, apart from a low score of
POMS confusion, which would be weak evi-
dence in substantiating the adverse effects on
the nervous system.
Letz and Gerr (1994a, 1994b) investigated
the confounding factors that could affect nerve
conduction velocity and amplitude as well as
vibrotactile and thermal thresholds, based on
data from 4,464 subjects. Their studies
revealed that the major covariates were height,
examiner, skin temperature, and body mass
index for sural sensory nerve and height, exam-
iner, age, and body mass index for peroneal
motor nerve conduction velocities. For vibro-
tactile threshold in toe, the major covariates
were height, examiner, age, and body mass
index. Our study design could control for the
effect of examiner-, sex-, and age-matching
pairs but not skin temperature-, body height-,
or body mass index-matching pairs. Although
body height was comparable on average
between the exposure group and the controls
and workers were acclimated to the room tem-
perature before the electrophysiologic studies,
the lack of pair matching for height, skin tem-
perature, and body mass index should be care-
fully noted as a limitation of this study.
Previous animal experiments demonstrated that
exposure to 1-BP disrupted the estrous cycle
and inhibited follicular development (Yamada
et al. 2003). Two patients who worked in a
cushion company in the United States also
reported temporary irregularities of menstrual
cycle (Ichihara et al. 2002). Although the expo-
sure level for the two patients was not evaluated
directly, such levels would be higher than
60–261 ppm, which were determined with the
third case from the same factory after the for-
mer two cases were identiﬁed and ventilation
was improved in the workplace. On the other
hand, our study did not demonstrate signiﬁ-
cant differences in the prevalence of menstrual
cycle abnormalities between the two groups.
This might be due to the difference in expo-
sure levels between U.S. cases (≥ 60–261 ppm)
and our Chinese 1-BP factory workers
(0.34–49.19 ppm).
Comparisons based on the exposure period
showed higher levels of FSH and LH in the
longer-exposure group than in shorter-expo-
sure group. One explanation for this difference
is that our group included four elderly women,
who were excluded from the paired t-test
analysis because of the lack of matched con-
trols and who had high levels of FSH
(42–100 mIU/mL) and LH (16–42 mIU/mL).
Analysis based on exposure level did not show
any relationship between exposure levels and
these parameters, which were different between
the exposure group and age-matched controls
(paired t-test). The present analysis by exposure
period and level has certain limitations. First,
the number of subjects was too small and did
not control for age. Second, the experimental
design allowed only a single measurement of
the exposure level, although the task of workers
was not fixed and thus the exposure levels
could vary. The exposure levels in 1999 in the
same factory ranged from 0.9 to 170.5 ppm
(geometric mean = 52.5 ppm) (Ichihara et al.
Environmental Medicine | Ichihara et al.
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Table 7. Stabilometer test results of 1-BP exposure group and controls. 
Age-matched Age-matched
1991 Workers controls 1999 Workers controls
No. (pairs) 23 12
LNG (cm)
Eyes open 71.7 ± 15.5 69.9 ± 20.8 71.5 ± 19.3 74.0 ± 19.4
Eyes closed 100.4 ± 25.1 91.1 ± 27.3 106.3 ± 29.7 95.0 ± 26.0
E AREA (cm2)
Eyes open 3.38 ± 1.26 3.69 ± 2.86 3.60 ± 1.52 3.88 ± 2.64
Eyes closed 4.94 ± 2.27 4.56 ± 3.62 5.65 ± 2.67 4.80 ± 4.15
LNG E AREA (per cm)
Eyes open 22.9 ± 6.3 24.9 ± 10.9 21.8 ± 6.6 26.3 ± 13.7
Eyes closed 23.1 ± 7.9 26.3 ± 10.4 22.0 ± 8.8 28.8 ± 12.2
REC AREA (cm2) 
Eyes open 7.53 ± 2.76 8.26 ± 6.39 7.87 ± 3.42 8.51 ± 6.08
Eyes closed 10.5 ± 5.6 10.3 ± 8.6 12.8 ± 6.1 10.5 ± 9.6
RMS (cm2)
Eyes open 1.62 ± 0.70 1.98 ± 1.67 1.82 ± 0.91 2.09 ± 1.46
Eyes closed 2.05 ± 1.01 2.05 ± 1.65 2.30 ± 1.25 2.22 ± 2.01
Mx (cm)
Eyes open 0.019 ± 0.581 –0.123 ± 1.162 –0.166 ± 0.485 –0.008 ± 0.724
Eyes closed 0.010 ± 0.573 0.053 ± 1.228 –0.044 ± 0.557 0.217 ± 0.679
My (cm)
Eyes open –2.43 ± 1.15 –2.09 ± 1.37 –2.70 ± 1.05 –2.20 ± 1.41
Eyes closed –2.29 ± 1.06 –2.06 ± 1.28 –2.50 ± 0.95 –2.41 ± 1.07
XO (cm)
Eyes open –0.004 ± 0.621 –0.142 ± 1.170 –0.186 ± 0.627  –0.009 ± 0.756
Eyes closed 0.119 ± 0.657 –0.003 ± 1.347 0.106 ± 0.771 0.231 ± 0.788
YO (cm)
Eyes open –2.50 ± 1.15 –2.07 ± 1.39 –2.79 ± 1.14 –2.22 ± 1.41
Eyes closed –2.29 ± 1.01 –2.30 ± 1.42 –2.48 ± 0.86 –2.48 ± 1.09
Power spectrum of x-axis (lateral)
Eyes open (%)
0.02–0.2 Hz 61.1 ± 12.4 54.7 ± 17.0 62.5 ± 12.1 53.7 ± 14.5
0.2–2.0 Hz 38.5 ± 12.3 42.1 ± 13.6 37.1 ± 11.9 45.8 ± 14.4
2.0–10 Hz 0.36 ± 0.21* 0.46 ± 0.21 0.38 ± 0.24 0.46 ± 0.21
Eyes closed (%)
0.02–0.2 Hz 45.7 ± 17.3 47.9 ± 12.2 48.5 ± 17.8 46.1 ± 12.7
0.2–2.0 Hz 52.5 ± 19.7 49.2 ± 16.3 48.4 ± 21.8 49.2 ± 19.7
2.0–10 Hz 0.53 ± 0.37 0.59 ± 0.33 0.60 ± 0.44 0.58 ± 0.34
Power spectrum of y-axis (anteroposterior)
Eyes open (%)
0.02–0.2 Hz 66.6 ± 14.0 70.7 ± 11.4 73.5 ± 11.1 70.9 ± 10.1
0.2–2.0 Hz 32.4 ± 12.8 28.9 ± 11.4 26.1 ± 11.1 28.6 ± 10.1
2.0–10 Hz 0.97 ± 2.62 0.42 ± 0.28 0.35 ± 0.16 0.45 ± 0.35
Eyes closed (%)
0.02–0.2 Hz 51.6 ± 14.0* 61.2 ± 13.7 54.0 ± 11.6 55.0 ± 11.2
0.2–2.0 Hz 47.3 ± 13.0* 38.3 ± 13.7 45.4 ± 11.6 44.4 ± 11.2
2.0–10 Hz 1.03 ± 2.38 0.50 ± 0.28 0.56 ± 0.26 0.57 ± 0.25
Abbreviations: E, envelope; LNG, length of excursion; Mx, mean of x-axis (lateral) component of each recorded points;
My, mean of y-axis (anteroposterior) component of each recorded points; REC AREA, rectangular area; RMS, root mean
square area; XO, center of range of x-axis component of points; YO, center of range of y-axis component of points. Data
are mean ± SD. 
*p < 0.05, paired t-test. No signiﬁcant difference was found between the exposed group and the controls in the Romberg
quotient for all items (the ratio of values measured with eyes closed to the values with eyes open; data not shown).2004), which was far higher than in the pre-
sent study. It is possible that the workers were
exposed to 1-BP at higher levels than those
measured in our study. Further assessment of
long-term exposure levels is required to deter-
mine the relationship between 1-BP and
exposure levels.
In summary, the present study suggested
that exposure to 1-BP produces adverse effects
on peripheral sensory and motor nerves and/or
the central nervous system in humans.
Estimation of long-term exposure levels is
required to confirm the precise association
between the health effects of 1-BP and exposure
levels.
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Correction
In the manuscript published online, the
numbers of workers listed in Table 1, espe-
cially in the footnotes, were incorrect; also,
the statistical significance of values for the
right and left ﬁngers for 1999 workers and
age-matched controls was incorrect. These
errors have been corrected here.